je.st
news
Tag: therapeutics
Frost & Sullivan Recognizes KAER's Game-Changing Innovating Aerosol Drug Delivery Methods For High-Dose Respiratory Disease Therapeutics
2013-02-27 02:15:32| drugdiscoveryonline Home Page
Based on its recent analysis of the aerosol drug delivery technology market, Frost & Sullivan recognizes KAER Biotherapeutics with the 2012 North America Frost & Sullivan Award for Technology Innovation for SUPRAER
Tags: methods
delivery
drug
disease
Galectin Therapeutics Announces Discovery Program For New Anti-Galectin Drugs In Collaboration With The University Of Georgia
2013-02-19 10:00:00| drugdiscoveryonline News Articles
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced recently the establishment of a collaborative drug discovery program with Dr. Geert-Jan Boons’ laboratory located in the Complex Carbohydrate Research Center at the University of Georgia
Tags: of
program
university
georgia
Galectin Therapeutics Announces Discovery Program For New Anti-Galectin Drugs In Collaboration With The University Of Georgia
2013-02-19 10:00:00| drugdiscoveryonline Home Page
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced recently the establishment of a collaborative drug discovery program with Dr. Geert-Jan Boons’ laboratory located in the Complex Carbohydrate Research Center at the University of Georgia
Tags: of
program
university
georgia
The Medicines Company And Alnylam Form Strategic Alliance To Develop And Commercialize RNAi Therapeutics Targeting PCSK9 For The Treatment Of Hypercholesterolemia
2013-02-04 07:00:00| drugdiscoveryonline News Articles
The Medicines Company and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced recently that they have formed an exclusive global alliance for the development and commercialization of Alnylam’s ALN-PCS RNAi therapeutic program for the treatment of hypercholesterolemia
PerkinElmer Launches Automated Workstation for Improved Process Development of Protein Therapeutics
2013-01-22 03:34:00| Electronics - Topix.net
PerkinElmer, Inc. , a global leader focused on improving the health and safety of people and the environment announced the launch of the JANUS BioTx ProTM automated workstation for improved process development of protein therapeutics at the 12th Annual Protein Science Week , January 21-25 in Palm Springs, Florida at booth #312. Designed for high ... (more)
Tags: development
process
improved
protein
Sites : [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] next »